Michel Streuli, Ph.D.

Research

After working in academia and biopharma, two colleagues and I formed Foundery Innovations. Foundery is an immunotherapy venture studio investing in direct scientific research that seeks to bridge the “therapeutic valley of death.” Foundery works closely with academic partners to help validate their drug development targets and biological concepts and then aims to maximize the value creation of discovery-stage drug development by forming multiple startups thematically aligned to develop and commercialize immunotherapeutics to treat cancer, inflammation, and autoimmunity. Using a studio, shared services model ensures continuity of the expertise-rich, immunology-focused drug development team.